Carl Denys Joins ChemImage as Vice President, Medical Devices

Advanced Imaging and Machine Learning Company Taps Medical Device Executive to Lead Expansion in Medical Applications for Patented Technology
Published: Dec. 1, 2021 at 2:39 PM CST

PITTSBURGH, Dec. 1, 2021 /PRNewswire/ -- ChemImage, a leader in advanced imaging and machine learning technology, has recruited Carl Denys to its executive management team. Mr. Denys will report to Patrick Treado, Founder and President of ChemImage, where he will focus on identifying expansion opportunities for the company's patented technology in medical applications.

ChemImage welcomes Carl Denys as their new Vice President, Medical Devices.
ChemImage welcomes Carl Denys as their new Vice President, Medical Devices.

As a seasoned executive, Mr. Denys has thrived on leading teams at image solution companies EOS Imaging, recently acquired by ATEC, and Deerfield Imaging, as well as the cardiology division of Boston Scientific and St. Jude Medical International Division.  He is a highly strategic and influential decision maker who promotes a customer-focused culture.

"As our business has grown and our focus turns more to solving complex medical challenges, we identified the need to add leadership with strong experience in medical devices," Treado stated. "Carl comes to us with experience in strategic planning, sales, marketing, and business development with global organizations. We are confident that he will help us to continue to grow in the medical device space."

Mr. Denys will lead the ChemImage marketing, business development, and product management teams. He will focus on the application of ChemImage technology for diagnostic endoscopy, as well as the CardioVere product that focuses on quantifying pre-clinical congestion in heart failure patients. Additionally, he will identify and seek out other opportunities for application of the technology toward the company's primary goal of enabling the Awareness of Things® in Life Sciences.

For more information on ChemImage and Awareness of Things®, please visit chemimage.com.

About ChemImage Corporation

ChemImage Corporation is committed to empowering the world with real-time autonomous smart chemical imaging technology to enhance users' situational awareness and decision making. The company's proprietary, state-of-the-art chemical imaging sensors, algorithms, computer vision solutions, and analysis software empower medical device, pharmaceutical and other life science companies, as well as security and law enforcement professionals to take on the world's most challenging health and safety needs with the Awareness of Things® (AoT®). With performance leading chemical imaging technology and advanced software and algorithms, ChemImage strives to bring a new level of situational awareness to people in their everyday lives. For more information, visit www.chemimage.com.

Advanced imaging and machine learning company taps Medical Device Executive to lead expansion...
Advanced imaging and machine learning company taps Medical Device Executive to lead expansion in medical applications for patented technology.

View original content to download multimedia:

SOURCE ChemImage Corporation

The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.